z-logo
open-access-imgOpen Access
Human coronavirus OC43 infection associated pneumonia in a girl with acute lymphoblastic leukemia
Author(s) -
TsungYen Chang,
Chia-Jui Du,
Chih Hsiang Chang,
Shih-Hsiang Chen,
ChihJung Chen,
ChihYung Chiu,
Cheng-Hsun Chiu
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000021520
Subject(s) - medicine , pneumonia , coronavirus , neutropenia , lymphoblastic leukemia , respiratory system , leukemia , pediatrics , intensive care medicine , covid-19 , chemotherapy , infectious disease (medical specialty) , disease
Rationale: Information regarding the clinical features and outcomes of pneumonia due to an infection with human coronavirus (HCoV)-OC43 in children with cancer is rare. This report presents the clinical features in terms of chest CT scan images which may be used to identify cases of HCoV-OC43 infection induced pneumonia in immunocompromised children. Patient concerns: We report here a girl with acute lymphoblastic leukemia who developed respiratory symptoms during febrile neutropenia. Rapid clinical progression and nodular lesions on her chest X-ray and computed tomography scans were suggestive of a pulmonary fungal infection. Diagnosis: A series of tests eventually confirmed the exclusive presence of HCoV-OC43 by the FilmArray Respiratory Panel from a throat swab sample. Interventions: After the diagnosis was confirmed, the antimicrobial agents initially administered were discontinued. Outcomes: Although the chest CT scan images looked severe, the clinical course of the infection induced pneumonia was benign. The respiratory status of the patient was completely resolved in 2 weeks. Lessons: This report highlights the importance of early identification of respiratory viruses, via the realization of their clinical characteristics, which helps reduce the duration of administration of antimicrobial agents in this setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here